Number of the records: 1
NSCLC: from tumorigenesis, immune checkpoint misuse to current and future targeted therapy
- 1.Kafkova, L. R., Mierzwicka, J. M., Chakraborty, P., Jakubec, P., Fischer, O., Škarda, J., Malý, P., Raška, M. NSCLC: from tumorigenesis, immune checkpoint misuse to current and future targeted therapy. Frontiers in Immunology. 2024, 15(FEB 7 2024), 1342086. ISSN 1664-3224. E-ISSN 1664-3224. Available: https://doi.org/10.3389/fimmu.2024.1342086.
Number of the records: 1